• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用亚洲合作研究网络对抗抗菌素耐药性。

Leveraging collaborative research networks against antimicrobial resistance in Asia.

机构信息

Saw Swee Hock School of Public Health, National University of Singapore, Tahir Foundation Building, Singapore, Singapore.

School of Government & Public Policy, University of Arizona, Tucson, AZ, United States.

出版信息

Front Public Health. 2023 Dec 7;11:1191036. doi: 10.3389/fpubh.2023.1191036. eCollection 2023.

DOI:10.3389/fpubh.2023.1191036
PMID:38146479
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10749297/
Abstract

BACKGROUND

Antimicrobial resistance (AMR) is a global health security threat requiring research collaboration globally and regionally. Despite repeated calls for international research collaboration in Asia, literature analyzing the nature of collaborative AMR research in Asia has been sparse. This study aims to describe the characteristics of the AMR research network in Asia and investigate the factors influencing collaborative tie formation between organizations.

METHODS

We carried out a mixed-methods study by combining social network analysis (SNA) and in-depth interviews. SNA was first conducted on primary data to describe the characteristics of the AMR research network in Asia. Exponential random graph models (ERGMs) were then used to examine the influence of factors such as organization type, country affluence levels, regional proximity and One Health research on collaborative tie formation among organizations. In-depth interviews were conducted with network participants to provide contextual insights to the quantitative data.

RESULTS

The results reveal that the research network exhibits a core-periphery structure, where a minority of organizations have a significantly higher number of collaborations with others. The most influential organizations in the network are academic institutions from high-income countries within and outside Asia. The ERGM results demonstrate that organizations prefer to collaborate with others of similar organization types, country-based affluence levels and One Health domains of focus, but also with others across different World Health Organization regions. The qualitative analysis identified three main themes: the challenges that impede collaboration, the central role of academic institutions, and the nature of collaborations across One Health domains, giving rise to important empirical milestones in understanding AMR research in Asia.

CONCLUSION

We thus recommend leveraging academic institutions as "integrators" to bridge differences, increasing funds channelled towards research capacity building to alleviate structural barriers to collaboration, streamlining collaborative mechanisms to overcome cumbersome administrative hurdles, and increasing efforts to establish trust between all organizations.

摘要

背景

抗菌药物耐药性(AMR)是对全球卫生安全的威胁,需要在全球和区域范围内开展研究合作。尽管一再呼吁在亚洲开展国际研究合作,但分析亚洲合作抗菌药物耐药性研究性质的文献却很少。本研究旨在描述亚洲 AMR 研究网络的特征,并探讨影响组织间合作关系形成的因素。

方法

我们采用混合方法研究,将社会网络分析(SNA)与深入访谈相结合。首先在初级数据上进行 SNA,以描述亚洲 AMR 研究网络的特征。然后使用指数随机图模型(ERGM)来检验组织类型、国家富裕程度、区域接近程度和“One Health”研究等因素对组织间合作关系形成的影响。对网络参与者进行深入访谈,为定量数据提供背景洞察。

结果

研究结果表明,研究网络呈现出核心-边缘结构,少数组织与其他组织的合作数量明显更多。网络中最具影响力的组织是来自亚洲内外高收入国家的学术机构。ERGM 结果表明,组织倾向于与具有类似组织类型、基于国家的富裕程度和“One Health”重点领域的其他组织合作,但也与来自不同世界卫生组织区域的组织合作。定性分析确定了三个主题:阻碍合作的挑战、学术机构的核心作用以及跨越“One Health”领域的合作性质,这为理解亚洲 AMR 研究提供了重要的经验里程碑。

结论

因此,我们建议利用学术机构作为“整合者”来弥合差异,增加用于研究能力建设的资金,以减轻合作的结构性障碍,简化合作机制以克服繁琐的行政障碍,并加强所有组织之间的信任建立。

相似文献

1
Leveraging collaborative research networks against antimicrobial resistance in Asia.利用亚洲合作研究网络对抗抗菌素耐药性。
Front Public Health. 2023 Dec 7;11:1191036. doi: 10.3389/fpubh.2023.1191036. eCollection 2023.
2
Antimicrobial Resistance Research Collaborations in Asia: Challenges and Opportunities to Equitable Partnerships.亚洲的抗菌药物耐药性研究合作:公平伙伴关系面临的挑战与机遇
Antibiotics (Basel). 2022 Jun 1;11(6):755. doi: 10.3390/antibiotics11060755.
3
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
4
Assessment of regional networks on nutrition in South Asia: a multi-methods study.南亚营养区域网络评估:一项多方法研究。
BMC Public Health. 2022 Jan 26;22(1):174. doi: 10.1186/s12889-022-12585-3.
5
Building resilient and responsive research collaborations to tackle antimicrobial resistance-Lessons learnt from India, South Africa, and UK.建立有弹性和响应能力的研究合作关系,以应对抗微生物药物耐药性——来自印度、南非和英国的经验教训。
Int J Infect Dis. 2020 Nov;100:278-282. doi: 10.1016/j.ijid.2020.08.057. Epub 2020 Aug 27.
6
Broadening the infection prevention and control network globally; 2017 Geneva IPC-think tank (part 3).全球拓宽感染预防与控制网络;2017 年日内瓦感染预防与控制智库(第三部分)。
Antimicrob Resist Infect Control. 2019 May 10;8:74. doi: 10.1186/s13756-019-0528-0. eCollection 2019.
7
Antimicrobial Resistance in the Asia Pacific region: a meeting report.亚太地区的抗微生物药物耐药性:会议报告。
Antimicrob Resist Infect Control. 2019 Dec 18;8:202. doi: 10.1186/s13756-019-0654-8. eCollection 2019.
8
How to move towards One Health surveillance? A qualitative study exploring the factors influencing collaborations between antimicrobial resistance surveillance programmes in France.如何迈向“同一健康”监测?一项定性研究,探讨影响法国抗菌药物耐药性监测计划之间合作的因素。
Front Public Health. 2023 Jul 11;11:1123189. doi: 10.3389/fpubh.2023.1123189. eCollection 2023.
9
The challenges of investigating antimicrobial resistance in Vietnam - what benefits does a One Health approach offer the animal and human health sectors?越南抗菌药物耐药性研究面临的挑战——“同一健康”方法对动物和人类健康部门有何裨益?
BMC Public Health. 2020 Feb 11;20(1):213. doi: 10.1186/s12889-020-8319-3.
10
The burden of bacterial antimicrobial resistance in the WHO European region in 2019: a cross-country systematic analysis.2019 年世卫组织欧洲区域细菌对抗菌药物耐药性的负担:跨国系统分析。
Lancet Public Health. 2022 Nov;7(11):e897-e913. doi: 10.1016/S2468-2667(22)00225-0. Epub 2022 Oct 14.

引用本文的文献

1
Research on the evolution of biotechnology cooperation networks - a study based on patent data in China from 2004 to 2023.生物技术合作网络的演化研究——基于2004年至2023年中国专利数据的研究
Front Public Health. 2025 Mar 13;13:1437212. doi: 10.3389/fpubh.2025.1437212. eCollection 2025.
2
Understanding the interests of academics from diverse disciplines to identify the prospective focus for a UK-based transdisciplinary network involving farm-to-fork stakeholders on antimicrobial resistance in agrifood systems: An online survey.了解来自不同学科的学者的兴趣,以确定一个涉及农业食品系统中从农场到餐桌各利益相关方的英国跨学科网络在抗菌药物耐药性方面的潜在重点:一项在线调查。
One Health. 2024 Aug 26;19:100884. doi: 10.1016/j.onehlt.2024.100884. eCollection 2024 Dec.
3

本文引用的文献

1
Antimicrobial Resistance Research Collaborations in Asia: Challenges and Opportunities to Equitable Partnerships.亚洲的抗菌药物耐药性研究合作:公平伙伴关系面临的挑战与机遇
Antibiotics (Basel). 2022 Jun 1;11(6):755. doi: 10.3390/antibiotics11060755.
2
A 'whole of United Nations approach' to tackle antimicrobial resistance? A mapping of the mandate and activities of international organisations.采取“联合国整体办法”防治抗微生物药物耐药性? 对国际组织的任务和活动进行的制图。
BMJ Glob Health. 2022 May;7(5). doi: 10.1136/bmjgh-2021-008181.
3
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.
A Situation Analysis of the Capacity of Laboratories in Faith-Based Hospitals in Zambia to Conduct Surveillance of Antimicrobial Resistance: Opportunities to Improve Diagnostic Stewardship.赞比亚教会医院开展抗菌药物耐药性监测的实验室能力情况分析:改善诊断管理的机遇
Microorganisms. 2024 Aug 17;12(8):1697. doi: 10.3390/microorganisms12081697.
2019 年全球细菌对抗菌药物耐药性的负担:系统分析。
Lancet. 2022 Feb 12;399(10325):629-655. doi: 10.1016/S0140-6736(21)02724-0. Epub 2022 Jan 19.
4
Antimicrobial resistance and COVID-19: Intersections and implications.抗微生物药物耐药性与 COVID-19:交叉与影响。
Elife. 2021 Feb 16;10:e64139. doi: 10.7554/eLife.64139.
5
A decade of antimicrobial resistance research in social science fields: a scientometric review.十年来社会科学领域的抗菌药物耐药性研究:科学计量学综述。
Antimicrob Resist Infect Control. 2020 Nov 4;9(1):178. doi: 10.1186/s13756-020-00834-2.
6
Antimicrobial Resistance in the Asia Pacific region: a meeting report.亚太地区的抗微生物药物耐药性:会议报告。
Antimicrob Resist Infect Control. 2019 Dec 18;8:202. doi: 10.1186/s13756-019-0654-8. eCollection 2019.
7
The state of social science research on antimicrobial resistance.抗菌药物耐药性的社会科学研究现状。
Soc Sci Med. 2019 Dec;242:112596. doi: 10.1016/j.socscimed.2019.112596. Epub 2019 Oct 11.
8
Something Borrowed, Something New: A Governance and Social Construction Framework to Investigate Power Relations and Responses of Diverse Stakeholders to Policies Addressing Antimicrobial Resistance.借来之物,新生之事:一个治理与社会建构框架,用于调查权力关系以及不同利益相关者对解决抗菌药物耐药性政策的反应。
Antibiotics (Basel). 2018 Dec 24;8(1):3. doi: 10.3390/antibiotics8010003.
9
China-United States Research Collaborations in Antimicrobial Resistance.中美抗菌药物耐药性研究合作。
Clin Infect Dis. 2018 Nov 13;67(suppl_2):S142-S145. doi: 10.1093/cid/ciy694.
10
Antimicrobial resistance in South East Asia: time to ask the right questions.东南亚的抗菌素耐药性:是时候提出正确的问题了。
Glob Health Action. 2018;11(1):1483637. doi: 10.1080/16549716.2018.1483637.